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Abstract
Background: In mammalian cells, the quality control (QC) of properly folded proteins is monitored in the early
secretory pathway, particularly in the endoplasmic reticulum (ER). Several proteins, including our protein of interest,
major histocompatibility complex class I (MHC class I), can bypass the first line of ER-QC and reside in post-ER
compartments in an unfolded form. Such forms entail both monomeric and dimeric structures that are devoid of
peptides and thus cannot fulfill the immunological function of antigen presentation at the cell surface. MHC class
I structures become mature and properly folded once loaded with the appropriate peptides in the framework of
the peptide loading complex (PLC). Despite the flood of information on the diverse trafficking behavior of different
MHC class I alleles, there is still controversy on the actual trajectory followed by improperly folded murine MHC
class I alleles, namely H-2Kb. In this study, we employ an in vitro rapamycin trapping assay, live cell imaging, and a
biochemical COPII budding approach to further investigate the trafficking of H-2Kb beyond the level of the ER.
Results: We confirm the egress of H-2Kb in an unfolded form to a post-ER compartment from where they can
cycle back to the ER. Deciphering the exact identity of the post-ER compartment by laser scanning microscopy did
not only point to the existence of the ERGIC and cis-Golgi compartments as residency areas for unfolded proteins,
but also to the involvement of an addional compartment, that lies in close proximity and possesses high
resemblance to the aforementioned compartments. Interestingly, we were capable of showing using the same
rapamycin trapping assay that H-2Kb can undergo a potential maturation event during their cycling; this is attained
upon addition of peptides and trapping of accumulated post-ER molecules at the cell surface.
Conclusions: Our findings deepen the understanding of H-2Kb trafficking outside the ER and pave the way to
decipher the role and the trafficking of certain PLC chaperones, such as tapasin, throughout H-2Kb post-ER QC.
Finally, we demonstrate the plausible usage of the rapamycin assay to assess the trafficking of defected proteins
especially in diseases and under therapeutic studies.
Keywords: (QC) quality control, (MHC) Major histocompatibility complex, Intracellular trafficking, Protein sorting,
Rapamycin trapping assay
Background
Like other transmembrane glycoproteins, major histo-
compatibility complex (MHC)1 class I molecules are
subject to cellular quality-control (QC) during folding
and maturation. A substantial body of work has investi-
gated the intracellular trafficking of MHC class I from
its biosynthesis in the endoplasmic reticulum (ER) to its
deposition at the cell surface for its proper function. To
initiate the journey, the free heavy chain (FHC) of MHC
class I interacts with the ER chaperone protein calnexin
and with the protein disulfide isomerase ERp57 until it
has folded and associated with the light chain, beta 2
microglobulin (β2m). In case they pass the initial folding
hurdle, they can bind to the light chain, β2m, forming
dimers that are recognized by the lectin chaperone,
calreticulin; together with three other proteins, tapasin,
ERp57, and TAP, they form the class I peptide loading
complex (PLC) [1]. Tapasin plays a crucial role in the
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maturation of MHC class I molecules by editing high
affinity peptides onto MHC class I grooves. Tapasin also
bridges MHC class I to TAP, the transporter associated
with antigen processing, thereby enhancing peptide
loading onto MHC class I.
It has been shown that dimers can leave the ER to the
cis-Golgi from where they cycle back to the ER [2].
Thus, another step of QC at the cis side of the Golgi
apparatus is needed to hinder their egress to the cell
surface and ultimately direct their route back to the ER.
This retrograde pathway is highly mediated by calreticu-
lin [3]. During the ER-Golgi cycle, the PLC is believed to
assist the heavy chain- β2m dimers to bind specific
peptides into their binding groove [4]. Susbequently, the
peptide-HC-β2m complexes dissociate from the PLC and
move as completely folded molecules through the secretory
pathway to the cell surface to elicit an immune reponse by
cytotoxic T cells (CTL) in case of infection.
Controlling the post-ER trafficking of MHC class I and
their ER-Golgi cycle is very vital to the health of the cell.
Any uncontrolled trafficking might lead to the escape of
empty dimers or FHC to the cell surface contributing to
certain diseases, such as spondyloarthropathy [5, 6].
Furthermore, empty dimers or monomers of MHC class
I at the cell surface can bind peptides [7, 8] and become
recognized by CTL. Thus, they can trigger the death of a
healthy cell by binding to exogenous non-self peptides
from the extracellular space.
Despite the flood of scientific studies that exist in the
literature on the post-ER QC of partially folded MHC
class I, there is no single mechanism underlying the
behavior of different MHC class I allotypes during the
ER-Golgi cycle. For instance, it is well reported that
partially loaded human allotypes, HLA-B5 and HLA-A2,
can reach the Golgi where they undergo peptide-loading
and exit to the cell surface [9], whereas dimers of HLA-
B27 accumulate in a subcompartment of the ER where
they are destined for degradation by ubiquitination [10].
Additionally, murine H-2Kd get sorted at the cis-Golgi
cisternae [11], and can reach the cell surface even in a
dimeric form. However, dimers or FHC of H2-Kb cannot
make it to the cell surface [12, 13] though dimers- but
not FHC- can reach post-ER compartment from where
their trajectory either back to the ER, or to the cell
surface, or to degradation is not fully discerned.
In this study, we employ the in vitro rapamycin-trapping
assay to further investigate the destiny of H-2Kb traffick-
ing from a post-ER compartment. The assay depends on
the generation of recombinant proteins tagged to
FK506 binding protein (FKBP) or FKBP-rapamycin
binding protein (FRB) that can interact upon addition
of rapamycin. Our results show that recombinant H-
2Kb mimic the localization pattern of endogenous
molecules, namely they are capable of exiting the ER
to the ER- Golgi intermediate complex (ERGIC) and/
or cis-Golgi compartments. Furthermore, recombinant
H-2Kb fused with FKBP or FRB are able to cycle back
to the ER as revealed by their trapping with an ER
localized marker. Trapping of H-2Kb was also exhib-
ited at the cell surface, demonstrating possible sorting
of partially folded molecules from the Golgi to the cell
surface. Our results demonstrate the plausible usage
of the rapamycin assay to assess the trafficking of
proteins especially in diseases and under therapeutic
studies. Finally, it paves the way to further explore the
peptide-rescue function of unloaded MHC class I in
post-ER compartments through their interaction with
certain members of the PLC complex.
Methods
Mammalian cells and transfections
Mouse embryonic fibroblasts (MEF), untransfected or
stably expressing H-2Kb-GFP, were obtained from Michael
Edidin (Johns Hopkins University, Maryland, US). Cells
were cultured in DMEM and supplemented with 10 %
heat-inactivated FCS and PSG (100 IU/ml penicillin,
100 mg/ml streptomycin, and 2 mM glutamine). Plain
cells were transiently transfected using the FuGENE
reagent (Roche Molecular Biochemicals, Indianapolis, IN).
For single transfection, 50 μl OptiMEM were mixed with
2 μl FuGENE and 400 ng/μl DNA. For multiple transfec-
tion, 50 μl OptiMEM were mixed with 3 μl FuGENE and
200 ng/μl of each DNA. The OptiMEM/FuGENE/DNA
mixture was kept at room temperature for 30 min and
then added to cells that were already in 120 μl of fresh
media. For the transfection to occur, the cells were
incubated for 4 to 5 h with the FuGENE mixture. After-
wards, 400 μl of new media were added, and cells were
incubated at 37 °C with 5 % CO2 overnight. The cell line,
293 T (ATCC® CRL-3216), is a highly transfectable deriva-
tive of human embryonic kidney 293 cells, and contains
the SV40 T-antigen.
Electroporation of Jurkat cells
One million cells were centrifuged at 200 x g for 10 min
at room temperature (RT). 2 μg of DNA were mixed in
82 μl Nucleofector solution V (Amaxa) and 18 μl of
supplement solution 1 at RT. In addition, the Nucleofec-
tor and supplement solutions were only mixed in the
quantities required for each experiment to make sure
that freshly mixed solutions were always used. After
centrifugation as above, the supernatant was discarded,
and the pellet was resuspended in 100 μl of the DNA/so-
lution mixture. The mixture was then transferred to a
sterile Amaxa cuvette, and cells were transfected using
program X-001. The cells were then left at RT for 10 min.
Meanwhile, RPMI medium (1.5 ml) was equilibrated in
the incubator to 37 °C. 500 μl of the equilibrated medium
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was then added into the cuvette (very smoothly the cells
were drawn into and out of the pipette tip three times,
such that all sedimented cells were resuspended). The
transfected cells were then plated and transferred immedi-
ately to the incubator at 37 °C with 5 % CO2. After 24 h,
1 ml of the supernatant was discarded, again care was
taken not to disturb the sedimented cells. The remaining
500 μl cells were resuspended and half of the amount was
used for the first-day experiment. To the remaining cells,
1250 μl of fresh media was added, and they were left to
grow for another 24 h for the second-day experiment. For
the first-day experiment, 250 μl of (about 600,000 cells)
were splitted into three different wells 83 μl/each of a
6-well Ibidi chamber (Ibidi, Munich, Germany). The
wells of the chamber were coated with 0.1 % polyly-
sine. L-polylysine (Sigma) for 40 min at RT, the wells
were then washed with water, and dried in the incuba-
tor for 10 min. Higher density of cells was bathed in a
lower volume of buffer to keep them in the field of
vision. Then to each of the wells, we added 117 μl of
CO2-independent buffer. Three different experiments
were performed in parallel.
Antibodies
The following monoclonal antibodies (mAbs) were
used: rabbit anti-GM130 (against the cytosolic tail of
GM130 and marking mostly the cis-Golgi cisternae,
purchased from BD Biosciences); rabbit anti-p58
(against p58 proteins in the ERGIC, a gift from Dr. Jaakko
Saraste, Bergen, Norway); rabbit anti-PDI (against PDI
proteins in the ER, a gift from Dr. Irina Majoul, Lübeck
University, Germany); anti-P8 serum (against H-2Kb, a
generous gift from Sjaak Neefjes, Netherlands Cancer
Institute, Amsterdam), rabbit anti-EEA1 (as an early
endosomal marker, BD Laboratories), α6F monoclonal
antibody against Na-K-ATPase α1-subunit (α6F) [14], and
the rabbit anti-murine tapasin antibody, 2668, against
residues 11 to 34 [15].
Chemicals and peptides
The peptide SIINFEKL (SL8) (from ovalbumin, 257–264;
purified by HPLC) was purchased from Biosyntan
(Berlin, Germany), dissolved with a stock concentration
of 2.5 mM, and used at a final concentration of 10 μM.
Peptides were added to the cells, without electropor-
ation, for one to two hours.
Cycloheximide (purchased from Applichem; lot
9 V001009) is used as an inhibitor of protein biosyn-
thesis in eukaryotes by blocking translational elongation.
was mixed in water to a stock concentration of 10 mg/
ml. The percentage of viability of cells as tested by
trypan blue was about 80 % in the presence of 50 μg/ml
of cycloheximide. Thus, we used this concentration
throughout all the conducted experiments. Rapamycin
(Sigma; lot 039 K4015) was mixed in DMSO at a stock
concentration of 1 mM and used at 1 μM. Rapamycin is
a small chemical with several roles among which it is
believed to mediate the interaction of FKBP and FRB
domains through its interface.
To avoid any effects of rapamycin on the trapping of
freshly synthesized molecules, cells were pretreated with
cycloheximide for ten minutes prior to rapamycin addition.
Isolation of DNA
Plasmid preparations from small overnight cultures
(1–5 ml) were either obtained using the QIAprep spin
kit according to supplier’s protocol (Qiagen, Hilden,
Germany), especially if the DNA was used for sequen-
cing, or prepared using the rapid boiling miniprep
method [16].
Immunofluorescence and temperature block
To arrest trafficking of class I molecules in the ERGIC,
cells expressing green fluorescent protein (GFP)- H-2Kb
fusion proteins were incubated for 2 h at 15 °C and then
fixed for 15 min at 15 °C with 4 % paraformaldehyde in
phosphate-buffered saline (PBS) [17]. To accumulate
class I molecules in the Golgi apparatus, cells were
incubated for 2 h at 20 °C [18] and then fixed for 15 min
at 20 °C with 4 % paraformaldehyde in PBS. After
fixation, cells were permeabilized and stained with the
indicated antibodies for one hour at room temperature.
To detect H-2Kb cycling, cells were cotransfected with Ii
and H-2Kb prior to their treatment with cycloheximide
and rapamycin. Ii corresponds to the invariant chain
associated with MHC class II moleucles and is usually
used as an ER marker. Cells were then fixed and
observed using a Zeiss LSM 510 confocal microscope.
Cells that were cotransfected with FKBP or FRB con-
structs were grown in the chambers of plastic micro-
scope slides (Ibidi, Martinsried, Germany) and fixed
with paraformaldehyde without permeabilization in the
wells. The cells were then observed directly in the
chambers without any mounting using confocal micro-
scope, LSM 510.
Pearson’s coefficient
For quantification, the plugin JACoP version 2.0 was
used in imageJ [19]. The pearson’s coefficient of the in-
tensities of the two channels was plotted by the red
channel on the x-coordinate (organelle markers) and the
green channel on the y-coordinate (H2-Kb). Pearson’s
coefficient provides an approximate of the rate of linear
association between the two used fluorochromes. Its
values range between −1 and 1 with zero no correlation
and negative values for negative correlation. Region of
interest (ROI) from selected cells was cropped, then
channels were split, and quantified using JACoP plugin.
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COPII vesicle formation assay
The COPII generation assay was carried out as described
by [3, 20, 21]. Briefly, mouse fibroblasts were radiola-
belled with [35S]-methionine for 30 min and then
harvested, resuspended in a low osmolarity buffer, and
broken with 40 passes through a 22G syringe needle.
After sedimenting nuclei and unbroken cells, the
medium-speed pellet (15,000xg, 5 min) was washed
twice and used as donor membranes for microsomes.
Budding reactions consisted of microsomal membranes,
pig brain cytosol, ATP regenerating system, and 0.2 mM
GTP. Vesicles were isolated from the supernatant result-
ing from a 15,000 x g spin and sedimented by a 100
000 x g centrifugation, lysed in 1 % digitonin in 50 mM
Tris-Cl (pH 7.5) and 150 mM NaCl, and radiolabelled
proteins were then immunoprecipitated using rabbit
serum specific for the GFP tag on H-2Kb (Fig. 4, lower
panel), or as a control for budding with Na+/K+-ATPase
antibodies (Fig. 4, upper panel). A peptide specific for
H-2Kb (sequence SIINFEKL in the single letter amino
acid code) was added to vesicles and to microsomes
during lysis at 1 μM final concentration. Samples were
treated with EndoF1 before SDS–PAGE, except for one
sample that was used as a size reference band for class I
heavy chain. Bands were quantified using ImageJ (1.44p)
analysis tool an their relative densities were plotted using
the highest peak of the budding reaction, donor mem-
branes with peptides, as a standard.
Immunoprecipitation
293 t cells were transfected with Venus-FRB- Kb or
cotransfected with Venus-FRB-tapasin and Venus-FRB-
Kb. At 6 h post transfection, cells were labelled for 14 h
with 35S-Met/Cys. Cells were lysed using 1 % digitonin.
IP was perfomed with anti-H-2Kb (P8).
Results and discussion
Endogenous and recombinant H-2Kb molecules accumu-
late in a post-ER compartment
To examine whether the localization of H-2Kb is similar
to previously reported data, we stained MEF cells with
anti-P8, an antiserum against the cytosolic tail of H-2Kb
[22]. Endogenous H-2Kb showed an ER-like stain in
addition to a juxtanuclear accumulation (Fig. 1a; arrows).
This accumulation resembled the ERGIC and cis-Golgi
markers (Fig. 1b, c). However, even blocking the exit of
H-2Kb from these compartments by low-temperature
incubations (15 °C for the ERGIC, and 20 °C for the
Golgi [23]), the pearsons’ coefficients for both the
ERGIC and cis-Golgi channels with respect to H-2Kb
channel did not show very high correlation with values
ranging between 0.68 and 0.77, respectively. The cell
surface was also stained, though weakly, in some cells
(asterisks). Similar to previously reported data,
endogenous H-2Kb exit the ER as partially or fully-
loaded and reach post-ER compartments, which cannot
be discerned by simple temperature blocks and colocali-
zation comparisons. In addition, a small pool of the mol-
ecules can reach the cell surface.
We next compared the endogenous expression pat-
tern with the green fluorescent protein (GFP) fusion
of H-2Kb, GFP-H-2Kb, in which the ER-lumenal amino
terminus of H-2Kb is fused to the carboxy terminus of
GFP [2]. We used an N-terminal fusion, rather than
the C-terminal fusion used by Edidin and coworkers
[24]. MEF cells expressing recombinant H-2Kb-GFP
were stained with different organelle markers. Then
the GFP fluorescence was compared with that of the
organelle antibody stain. In Fig. 2a, transfected cells
were stained with anti-PDI (protein disulfide isomer-
ase), an antibody that labels the ER peripheral tubules.
GFP-Kb fluorescence was found in the central rough
ER sheets, including the nuclear envelope, rather than
the ER peripheral tubules. Upon 15 °C block, again
inhibiting exit from the ERGIC, about 30 % of the cells
showed a complete overlap of the accumulated
molecules with the ERGIC area stained with anti-p58
antibody (Pearson’s coefficient ~ 0.83), and about add-
itional 10 % of the cells showed a partial overlap (Data
not shown) (Fig. 2b). A similar distribution pattern
was observed when the accumulation of GFP-Kb was
compared with the cis-Golgi marker, GM130, at 20 °C
(Pearson’s coefficient ~ 0.64; Fig. 2c). The post-ER
accumulation was not the result of endocytosed
molecules from the cell surface, since there was no
overlap between the fluorescence of GFP-Kb and the
endosomal marker, EEA1 (Pearson’s coefficient ~ 0.32;
Fig. 2d). Both H-2Kb endogenous and recombinant H-
2Kb-GFP molecules exhibit similar intracellular dis-
tribution though the cell surface signal was not
detected with the GFP fusions. The intensity signal
at the cell surface could be low due to the high
expression level of H-2Kb in the transfected cells.
Thus, the ratio of partially to fully loaded molecules
is highly masking the presence- if any- of cell
surface proteins.
Taken together, our results so far suggest that the
trafficking of a large pool of both endogenous and
recombinant H-2Kb is jammed outside the ER. The
calculated pearsons’ coefficients did not show complete
correlation between the colocalized H-2Kb and organelle
channels, but was slightly higher for the ERGIC than the
cis-Golgi. This underlying fact points up the possibility
of the involvement of another quality control compart-
ment that might resemble as well the ERGIC and cis-
Golgi compartments. This behavioral phenotype com-
pounded with the cell surface expression of molecules
might be restricted to MEF cells and is prone to
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variation based on the origin and overall characteristics
of the tested cell line.
H-2Kb exit the ER in COPII vesicles
To characterize the nature of the trafficking pathway
that H-2Kb follow to exit the ER, COPII vesicles that
carry proteins from the ER to the ERGIC in mammalian
cells were targeted [25]. COPII vesicles cannot be
isolated from extracts due to their short lifetime in cells.
Thus, they were produced from microsomal membranes
by an in vitro budding reaction that Springer et al. group
has established. [2, 26]. Different COPII formation reac-
tions were performed with microsomes of MEF cells in
the presence of cytosol (as a source of COPII compo-
nents), ATP, and wild type recombinant Sar1 protein
(the GTPase that drives COPII budding). Budded
Fig. 1 Endogenous H-2Kb accumulate in a juxtanuclear region and can reach the cell surface. MEF cells were fixed, permeabilized, and double
stained for H-2Kb with anti-P8 serum and for one of the early secretory organelles, either ER (anti-PDI), ERGIC (anti-p58), or cis-Golgi (GM130). Prior
to fixation, cells were either kept at 37 °C or incubated for 2 h at 15 °C or 20 °C, panels b and c, respectively. Most of the cells showed, in addition
to the ER pattern, a juxtanuclear accumulation (a, arrows) that partially overlapped with the ERGIC and cis-Golgi stains. Some of the cells also showed
weak cell surface stain (asterisk). Nuclei were stained with Draq5 as depicted in blue. All samples are shown in a bright-field mode to delineate the
overall structure of the stained cells. Region of interest (ROI) from selected cells is quantified and a scatter plot with pearson’s coefficient
is given.Scale bars, 10 μm
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vesicles were then isolated by differential centrifugation,
lysed, and GFP-H-2Kb or Na+/K+ ATPase, as a control
protein for trafficking [3], were immunoprecipitated with
anti-GFP serum and anti-Na+/K+ ATPase antibodies, re-
spectively (Fig. 3a). Proteins were then detected by SDS-
PAGE and autoradiography. In the absence of cytosol
(lane 3), absence of ATP (lane 4), or in the presence of
mutant Sar1(T39N) as a specific inhibitor for COPII ves-
icles (lane 5), the amounts of H-2Kb and ATPase found
in the vesicle fraction were reduced (Fig. 3, lanes 3 to 5).
The packaging efficiency for all the lanes was quantified
relative to lane 7 (Fig. 3b). Comparable budding efficiency
Fig. 2 Recombinant GFP-Kb also form a post-ER accumulation. MEF cells transiently transfected with GFP-Kb were fixed, permeabilized, and
stained with antibodies against PDI (a), p58 (b), or GM130 (c). Prior to fixation, cells were either kept at 37 °C or incubated for 1.5 h at
15 °C (b) or 20 °C (c). Scatter plots with pearson’s coefficient depict the fluorescence intensities of the secondary Ab (Cy3) on the x-axis
and the GFP fluorescence on the y-axis. Scale bars, 10 μm
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for both proteins was measured, with four fold reduction
in lanes 3 and 4. This indicates that the isolated vesicles
were indeed COPII vesicles. In lane 8, sample was left un-
treated with EndoF1 revealing a shift of H-2Kb alleles
from sensitive form (s)GFP- H-2Kb to glycosylated form
(g) GFP- H-2Kb. Thus, H-2Kb in COPII vesicles are
EndoF1-sensitive, revealing their trafficking out of the ER
en route to the ERGIC and cis-Golgi but they can not
travel beyond the median Golgi. Interestingly, addition of
peptides to the complete budding reaction (lane 1) or to
donor membranes (lane 7) did not increase the intensity
of packaged proteins pointing to the existence of
mostly unfolded heavy chains H-2Kb in COPII vesi-
cles. This can also point to the ER-egress of not only
partially folded proteins, but also heavy chains of H-
2Kb molecules.
In vitro FKBP/FRB rapamycin-trapping assay is adopted to
further confirm the trafficking of H-2Kb
To follow up on the above observation we used a rapa-
mycin trapping assay, which utilizes the non-covalent
crosslink that occurs between two domains, FKBP
(FK506 binding protein) and FRB (FKBP-rapamycin
binding domain), upon addition of rapamycin [27].
These domains were conjugated to the C-termini of the
Venus and Cerulean fluorescent proteins [28]. Cerulean-
FKBP and Venus-FRB were then fused to the amino
termini of H-2Kb, tapasin, or various organelle
markers (Table 1); in this way, triple fusions, such as
Venus-FRB-Kb and Venus-FRB-tapasin were generated.
Initially, we examined the proper size of these
constructs in 293 T cells (Fig. 4). 293 T cells were either
left untranfected (lane 1) or cotransfected with Venus-
Fig. 3 H-2Kb–GFP molecules exit the ER in COPII vesicles. COPII vesicles were generated by an in vitro reaction from MEF cells. Controls for this
reaction were the omission of cytosol (lane 3), ATP (lane 4), or addition of dominant-negative Sar1 (T39N; lane 5). COPII vesicles or the corresponding
donor microsomal membranes (after the reaction; lane 6–8) were lysed with detergent (in the presence of 10 μM peptide as indicated in
lanes 1 and 7). H-2Kb–GFP (upper panel) and Na+/K+ATPase (lower panel) were sequentially immunoprecipitated from the lysates with
anti-GFP serum and α6F antibodies, respectively as depicted in panel a. Immunoprecipitates were treated with EndoF1 (lanes 1–7). The
band intensities were quantified and plotted in panel (b). One out of three experiments is shown here
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FRB-Kb and Venus-FRB-tapasin (lane 2) or with Venus-
FRB-Kb and wt Tapasin (lane 3). H-2Kb were pulled
down with anti-P8 antibody (lanes 1 to 3) followed by
blotting with anti-tapasin antibody, #2668. Venus-FRB-
Kb had the expected size of approximately 80 kDa and
interacted with both Venus-FRB-Tapasin (lane 2) and
wild type tapasin (lane 3).
Because of the previous observation by us and others
that class I molecules cycle between the ER and the
Golgi at steady state [11, 20], we next examined the
cycling of accumulated MHC class I molecules in Jur-
kat cells using the rapamycin trapping assay. MEF cells
were substituted by Jurkats as the latter was easier to
double and triple transfect. In addition, Jurkats are lym-
phocytes with a better system that mimics and coordi-
nates the normal behavioral function of MHC class I
and the peptide loading complex proteins. Lastly, Jur-
kats possess a smaller surface area, which facilitates the
tracking of recycled molecules. We cotransfected Jurkat
cells with Venus-FRB-Kb and Cerulean-FKBP-Ii. Cells
showed Cerulean-FKBP-Ii expression in the ER,
whereas Venus-FRB-Kb was detected not only in the
ER, but also at the cell surface and in intracellular
accumulations (Fig. 5, first panel). If Venus-FRB-Kb cy-
cles back to the Golgi from post-ER compartment, then
accumulating molecules should be trapped by
Cerulean-FKBP-Ii in the ER upon addition of rapamy-
cin. Since, Ii protein is permanently residing in the ER,
then we expect any recycling H-2Kb to be trapped by Ii
resulting in a decrease of the fluorescence intensity of
the post-ER accumulated molecules over time. To rule
out the artifact of Ii trapping newly synthesized Kb in
the ER, we incubated the cells with cycloheximide for
ten minutes prior to rapamycin addition. Cyclohexi-
mide inhibits the elongation of protein translation and
thus, allows us to evaluate the ER-trapping of accumu-
lated H-2Kb rather than Kb already present in the ER.
Consistent with our hypothesis, we observed that the
accumulation of Venus-FRB-Kb disappeared after one
hour treatment with rapamycin (Fig. 5, second panel).
In the controls, without adding rapamycin or in the
absence of an FKBP domain, the accumulated pool of





























EGFP-H-2Kb was generated as described in Garstka et al. 2007. The Cerulean-
FKBP-Ii and Cerulean-FKBP-GPI constructs were obtained from Dr. Jennifer
Lippincott-Schwartz (NIH, Bethesda, US). The other constructs, Cerulean-FKBP-
p58, Venus-FRB-Kb, and Venus-FRB-Tapasin were generated using the
following primers
Fig. 4 Examining the proper size of recombinant Venus-FRB-Kb mol-
ecules in 293 T cells. Venus-FRB-Kb showed an estimate size of
80KDa and associated with both Venus-FRB-Tapasin (lane 2) and wild
type tapasin (lane 3)
Fig. 5 Cycling of Venus-FRB-Kb from post-ER compartment back to
the ER. Venus-FRB-Kb is trapped in the ER by Cerulean-FKBP-Ii upon
addition of rapaymcin. The fluorescence intensity of Venus-FRB-Kb
accumulation from the first panel disappears upon the addition of
rapamycin (1 mM) for 2 h (second panel). Trapping of Venus-FRB-Kb
molecules does not occur in the controls where rapamycin is absent
(first and third panels) or in the presence of Cerulean-Iip35 that lacks
the FKBP domain (fourth panel). Scale bars, 10 μm
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H-2Kb persisted even at prolonged incubation period.
This trimmed configuration of Cerulean-Ii, “No FKBP”,
offers a good control to directly assess the recycling
and trapping of Venus-FRB-Kb molecules. It is worth
noting that the around 40 % of the cells did not show a
disintegration of the accumulated molecules.
The disappearance of accumulated Venus-FRB-Kb over
time is not due to the disruption of the Golgi apparatus
Treatment of cells for prolonged period with cyclohexi-
mide might disrupt the structure of post-ER organelles,
since they depend on newly synthesized proteins to
maintain their integrity. On a related note, the traffick-
ing of Scy11 between the Golgi and ER is required for
the maintenance of the Golgi apparatus [29]. To test
whether the relocation of Venus-FRB-Kb molecules to
the ER is happening as a result of its trapping and not
due to the Golgi disassembly, we triple transfected Jurkat
cells with Venus-FRB-Kb, Cerulean-FKBP-Ii, and GalT-
mCherry. GalT (1,4-galactosyltransferase) is a marker
for the trans-Golgi membranes and the trans-Golgi net-
work. Cells were then either treated with cycloheximide
in the presence or absence of rapamycin, or left un-
treated. The Golgi structure (as detected by the fluores-
cence of GalT-mCherry) was maintained even after
prolonged (6 h) incubation with cycloheximide (Fig. 6,
first panel). Thus, the trapping effect is not mediated by
the disintegration of the Golgi structure, but rather re-
flects the recycling of our tracked proteins. Consistent
with our hypothesis, MHC class I trapping by Cerulean-
FKBP-Ii was again observed (Fig. 6, second panel). This
confirms the cycling of Venus-FRB-Kb molecules be-
tween the cis-Golgi and the ER and validates our assay.
Live- cell imaging to examine the cycling of recombinant
Venus-FRB-Kb
We next followed the fluorescence intensity of accu-
mulated Venus-FRB-Kb molecules in live cell micros-
copy over a time period of 45 min from the time of
rapamycin addition, which is ten to fifteen minutes
after addition of cycloheximide. The movie consists of
concatenated images taken at time interval of 2 min.
Each image is in turn obtained by a compilation of
four z-stacks (z = 1 μm). Six different images taken
from the movie at time points: 0, 6, 12, 18, 22, and
40 min are depicted in Fig. 7. The fluorescence inten-
sity (FI) of Venus-FRB-Kb was analyzed by calculating
Pearson’s coefficient from a circular region of interest
(ROI) drawn around the region in the double trans-
fected cell (red and green = RG), where the green in-
tensity is more concentrated and denser than the red
intensity (RG cell in Fig. 7a). As a control, Pearson’s
coefficient was calculated from an ROI around a sin-
gle transfected cell expressing only Cerulean-FKBP-Ii
(R cell in Fig. 7). The time-dependent decrease of the
accumulated pool of the RG cell is demonstrated by
the increase in the Pearson’s coefficient values over
time reaching almost 0.9 at around 40 min (Fig. 7b).
For the control cell (R cell), Pearson’s coefficient was
constant unaffected by rapamycin addition. Interest-
ingly, the percentage of cells showing a morphology
of MHC class I only in the ER, without any Golgi or
Fig. 6 Integrity of the Golgi apparatus in the presence of rapamycin. The Golgi structure is maintained even after six hours incubation of Jurkat
cells with cycloheximide and rapamycin. Jurkat cells triple transfected with Venus-FRB-Kb Cerulean-FKBP-Ii, and GalT-mCherry show intact Golgi
even after six hours treatment with cycloheximide and rapamycin. Scale bars, 10 μm
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cell surface expression, increased from 30 % to almost
70 % in the presence of rapamycin (Fig. 7c).
Egress of H-2Kb to the cell surface upon addition of
peptides
Finally we assessed the localization of Venus-FRB-Kb in
MEF cells. Similar to endogenous H-2Kb and of GFP-H-
2Kb, they were mostly localized to the ER and showed
an additional accumulation close to the nucleus with a
weak delineation of the cell surface (data not shown).
Cells were pretreated with cycloheximide for 10 min- to
avoid cross-linking of the nascent proteins in the ER-
prior to their one-hour incubation with or without
rapamycin.. As expected, after treatment with rapamycin,
60 % of the cells lacked a juxtanuclear accumulation and
mostly showed an ER-like pattern for Venus-FRB-Kb with
few vesicular structures that could be late endosomes
(data not shown). Trapping failed to occur in cells co-
transfected with Cerulean-FKBP-Ii and Venus-Kb lacking
the FRB domain (data not shown).
We next tested whether the cell surface presence of
Venus-FRB-Kb can be increased by trapping recombin-
ant Kb at the cell surface by Cerulean-FKBP-GPI. The
Cerulean-FKBP- protein is modified in the ER by its fu-
sion with a GPI (glycosylphosphatidylinositol) peptide
signal moiety that anchors it to the cholesterol-rich lipid
microdomains of the plasma membrane and thus main-
tains its steady state localization at the cell surface [30].
For this, we double transfected cells with Venus-FRB-Kb
and Cerulean-FKBP-GPI. To extend the residence time
of Venus-FRB-Kb at the cell surface, we added 10 μM of
high-affinity peptide (SIINFEKL in the single letter
amino acid code) to the medium for one hour. As shown
in Fig. 8, the addition of rapamycin to cells incubated
Fig. 7 Live cell imaging for Venus-FRB-Kb cycling. (a) Six different snapshots of live Jurkat cells coexpressing Venus-FRB-Kb and Cerulean-FKBP-Ii
(double-transfected red and green cell = RG) or expressing only one of the constructs (only Ii in red = R cell) were taken from a 45 min movie
(images were captured at a 2-min interval; snapshots are revealed at different allocated time points). Each image consists of four compiled
z-stacks, where each Δz = 1 μm. Before recording the movie, cells were transferred to a 37 °C heat stage in CO2-independent buffer and incubated
first with cycloheximide (10 μg/ml) for 10 min and then with rapamycin (1 μM). Pearson’s coefficient was calculated from each image by defining
a circular region of interest (ROI) around the Golgi area where the green fluorescence intensity of Venus-FRB-Kb accumulates (an arrow pointing
to the circle in the first panel). For the cell only expressing Cerulean-FKBP-Ii in red (R cell), the ROI was drawn around the entire cell. (b) The graph
shows the time-dependent change in Pearson’s coefficient based on the variation of the green fluorescence intensity with respect to the red
fluorescence in the chosen ROI. There is an increase in Pearson’s coefficient for the RG but not for the control (R) cell. (c) There is a 25 % increase
in the percentage of cells that show Venus-FRB-Kb localization in the ER upon addition of rapamycin (*p < 0.02). The error bars correspond to the
SEM values from 2 sets of experiments (n > 250)
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with cycloheximide and peptides increased the fluores-
cence of Venus-FRB-Kb at the cell surface. This advo-
cates the possible peptide-loading of H-2Kb in a post-ER
compartment, rescuing their egress to the cell surface.
More experiments should be done to reveal a clear sta-
tistics on the overall behavior of the cells.
Conclusion
Several reports have examined proteins that undergo post-
ER quality control; Examples include MHC class I partially-
folded dimers that reach post-ER compartments from where
they cycle back to the ER possibly by Bap31 [20] or calreti-
culin [3]; mutants of influenza hemagglutinin that leave the
ER to reach the plasma membrane for degradation by endo-
cytosis [31]; the N153D mutant of tissue non-specific alka-
line phosphatase (TNSALP) [32], which leaves the ER and
is retained in the cis-Golgi until degradation; and the
ts405 mutant form of the vesicular stomatitis virus G
protein (VSVG), which cycles between the Golgi and
ER until it is finally degraded by ERAD [33].
In this work, we used an exquisite rapamycin-
trapping assay to detect and confirm the trafficking
and sorting of MHC class I molecules, H-2Kb, from
post-ER compartments.
We provide biochemical evidence that in MEF cells,
H-2Kb exit the ER in COPII vesicles. This assay is well
established and monitored earlier in Springer’s labora-
tory in Germany. The result provides independent
biochemical evidence that indeed GFP-H2Kb can leave
the ER, and that the sorting-QC that determines the
intracellular transport of dimers is located in a post-ER
compartment. Interestingly, GFP-Kb molecules were
found in COPII vesicle fractions regardless of the
presence of peptides.
In addition, we present microscopic evidence that the
post-ER compartment where H-2Kb accumulate resem-
bles closely the ERGIC and/or the cis-Golgi compart-
ments. The central aim of this report was to assess the
destiny of the trafficking of H-2Kb accumulated mole-
cules. We were able to show that the majority of H-2Kb
alleles can cycle back to the ER as revealed by the in
vitro and in vivo trapping with an ER marker, Ii. Since
not all the molecules showed similar cycling pattern,
then we believe that there is a degradation pathway that
releases the stress of accumulating immature proteins
outside the ER. One possibility arising from the exit of
unfolded proteins from the ER is their degradation in an
ERGIC-expanded region [10] or in a QC compartment
(QCC) [34]. However, given that the PLC assists the
heavy chain- β2m dimers to bind peptides onto the class
I peptide binding groove [4] and based on what we have
shown that TAP is active in post-ER compartment, then
there is a substantial possibility of loading partially-
folded molecules with peptides during their ER-Golgi
cycle, as a rescuing event to further open the gate for
protein channeling to the cell surface.
The latter assumption is supported by our data on the
trapping of H-2Kb at the cell surface by GPI. We
showed that cells incubated with peptides exhibited a
cell surface stain that was upregulated in the presence of
rapamycin. Our report paves the way for further work to
decipher the trafficking of H-2Kb to the cell surface and
Fig. 8 Preliminary data on the trafficking of H-2Kb from post-ER compartment directly to the cell surface. MEF cells were double transfected with
Venus-FRB-Kb and Cerulean-FKBP-GPI. The invariant chain Ii is retained in the ER, whereas GPI can reach the cell surface. Cells treated with
cycloheximide and rapamycin without addition of peptides showed Venus-FRB-Kb in the ER with a faint delineation of the cell surface. From the intensity
RGB profile, the pseudo-color curves do not overlay. Cells treated with 10 μM of SIINFEKL peptides showed a clear cell surface stain that was more intense
in the presence of rapamycin. The RGB profile depicts an overlay of the fluorophore curves at the same distance. Scale bars, 10 μm
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to unravel the chaperones or proteins that mediate H-
2Kb trafficking and stability at the cell surface.
Finally, this assay can be extended to examine the
cycling of other ER chaperones, such as tapasin, that
has also been shown to partially exit the ER especially
in lymphocytes.
Endnotes
11 Abbreviations used: β2m, beta-2 microglobulin;
BFA, brefeldin A; CTL, cytotoxic T lymphocytes; ER,
endoplasmic reticulum; ERAD, ER-associated degrad-
ation; ER-QCC, endoplasmic reticulum quality control
compartment; FHC, free heavy chains; FKBP, FK506
binding protein; FRB, FKPB-rapamycin binding protein;
GFP, green fluorescent protein; GPI, glycosylphosphati-
dylinositol; HC, (MHC class I molecule) heavy chain;
MHC, Major histocompatibility complex; PLC, (MHC
class I) peptide loading complex; QC, quality control.
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